We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-8.85%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.16B
AUM Growth
-$246M
Cap. Flow
-$108M
Cap. Flow %
-9.27%
Top 10 Hldgs %
23.33%
Holding
205
New
58
Increased
35
Reduced
52
Closed
59

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$22.3M
2
VNT icon
Vontier
VNT
+$21.7M
3
SSNC icon
SS&C Technologies
SSNC
+$21.3M
4
IPGP icon
IPG Photonics
IPGP
+$21.3M
5
BKNG icon
Booking.com
BKNG
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 30.14%
2 Consumer Discretionary 16.46%
3 Communication Services 11.87%
4 Industrials 9.35%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRM icon
51
Salesforce
CRM
$162B
$7.74M 0.66%
53,787
+7,951
+17% +$1.35M
INGN icon
52
Inogen
INGN
$163M
$7.6M 0.65%
313,171
-293,351
-48% -$8.1M
CXW icon
53
CoreCivic
CXW
$3.26B
$7.34M 0.63%
830,846
+177,964
+27% +$1.8M
APP icon
54
Applovin
APP
$113B
$7.2M 0.62%
+369,366
New +$11M
BDC icon
55
Belden
BDC
$5.28B
$7.05M 0.61%
117,440
-212,577
-64% -$13.5M
INTC icon
56
Intel
INTC
$492B
$7.01M 0.6%
272,145
+118,626
+77% +$4.04M
AMK
57
DELISTED
AssetMark Financial Holdings, Inc.
AMK
$6.79M 0.58%
+371,267
New +$7.2M
SD icon
58
SandRidge Energy
SD
$531M
$6.58M 0.57%
403,279
+65,437
+19% +$1.18M
KGC icon
59
Kinross Gold
KGC
$32.5B
$6.37M 0.55%
1,695,319
-3,154,333
-65% -$10.7M
JACK icon
60
Jack in the Box
JACK
$340M
$6.35M 0.55%
85,721
-140,329
-62% -$10.6M
OGN icon
61
Organon & Co
OGN
$3.58B
$6.33M 0.54%
+270,313
New +$8.16M
ADEA icon
62
Adeia
ADEA
$3.07B
$6.32M 0.54%
1,689,482
-289,786
-15% -$1.19M
KOP icon
63
Koppers
KOP
$956M
$6.16M 0.53%
296,526
+59,061
+25% +$1.36M
DOW icon
64
Dow Inc
DOW
$22.1B
$5.97M 0.51%
+135,991
New +$6.89M
NWL icon
65
Newell Brands
NWL
$2.51B
$5.96M 0.51%
+429,127
New +$8.01M
EXPE icon
66
Expedia Group
EXPE
$37.7B
$5.77M 0.5%
+61,568
New +$6.28M
ST icon
67
Sensata Technologies
ST
$6.66B
$5.76M 0.49%
154,463
+45,450
+42% +$1.9M
CTSH icon
68
Cognizant
CTSH
$26.3B
$5.75M 0.49%
+100,180
New +$6.56M
CVSA
69
Covista Inc
CVSA
$4.38B
$5.56M 0.48%
152,539
-200,360
-57% -$7.65M
SAMG icon
70
Silvercrest Asset Management
SAMG
$77.6M
$5.48M 0.47%
335,164
-8,782
-3% -$157K
LASR icon
71
nLIGHT
LASR
$2.88B
$5.38M 0.46%
569,620
+121,527
+27% +$1.4M
CASA
72
DELISTED
Casa Systems, Inc. Common Stock
CASA
$5.29M 0.45%
1,689,275
+706,908
+72% +$2.79M
MG icon
73
Mistras Group
MG
$502M
$5.28M 0.45%
1,183,650
-23,041
-2% -$131K
OKTA icon
74
Okta
OKTA
$26.2B
$5.2M 0.45%
+91,500
New +$7.87M
BTG icon
75
B2Gold
BTG
$6.68B
$5.1M 0.44%
1,589,909
-2,969,574
-65% -$9.79M

Similar funds

Invenomic Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Invenomic Capital Management held 205 positions worth $1.16B, down 17% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $108M in Q3 2022, closing 59 positions and reducing 52 holdings. Its most notable exit was Cardinal Health, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Invenomic Capital Management opened a new position in Zoom worth $17.2M.

  • Invenomic Capital Management's largest Q3 2022 buy was Zoom: 234,351 shares worth $17.2M.
  • Invenomic Capital Management added most to IPG Photonics in Q3 2022, an estimated $21.3M increase.
  • Invenomic Capital Management's biggest Q3 2022 reduction was Belden, cutting an estimated $13.5M.
  • Invenomic Capital Management fully exited Cardinal Health in Q3 2022, selling an estimated $17.9M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.16B portfolio in Q3 2022.
  • Invenomic Capital Management opened 58 new positions and closed 59 in Q3 2022.
  • Invenomic Capital Management's portfolio value fell 17% quarter-over-quarter to $1.16B.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.